Towards Healthcare
Inflammatory Bowel Disease Treatment Market Size Envisioned at USD 33.19 Bill...

Inflammatory Bowel Disease Treatment Market Size Envisioned at USD 33.19 Billion by 2032

The report covers Inflammatory Bowel Disease (IBD) Treatment Market Size, Companies and Segmentations into Crohn's Disease and Ulcerative Colitis, with treatment options including Corticosteroids, Aminosalicylates, TNF Inhibitors, IL Inhibitors, JAK Inhibitors, Anti-Integrin Medications and others. These treatments can be administered orally or via injection and they are typically distributed through hospital, retail and online pharmacies. The report offers the value (in USD Billion) for the above segments.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Inflammatory Bowel Disease Treatment Market Assessment

  • Overview
  • Global Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Crohn's Disease
    • Ulcerative Colitis
  • Global Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Corticosteroids
    • Aminosalicylates
    • TNF Inhibitors
    • IL Inhibitors
    • JAK Inhibitors
    • Anti-Integrin
    • Others
  • Global Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Injectable
  • Global Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
  • Global Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Middle East and Africa
    • South America

North America Inflammatory Bowel Disease Treatment Market Assessment

  • Overview
  • North America Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Crohn's Disease
    • Ulcerative Colitis
  • North America Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Corticosteroids
    • Aminosalicylates
    • TNF Inhibitors
    • IL Inhibitors
    • JAK Inhibitors
    • Anti-Integrin
    • Others
  • North America Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Injectable
  • North America Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

Europe Inflammatory Bowel Disease Treatment Market Assessment

  • Overview
  • Europe Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Crohn's Disease
    • Ulcerative Colitis
  • Europe Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Corticosteroids
    • Aminosalicylates
    • TNF Inhibitors
    • IL Inhibitors
    • JAK Inhibitors
    • Anti-Integrin
    • Others
  • Europe Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Injectable
  • Europe Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

Asia Pacific Inflammatory Bowel Disease Treatment Market Assessment

  • Overview
  • Asia Pacific Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Crohn's Disease
    • Ulcerative Colitis
  • Asia Pacific Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Corticosteroids
    • Aminosalicylates
    • TNF Inhibitors
    • IL Inhibitors
    • JAK Inhibitors
    • Anti-Integrin
    • Others
  • Asia Pacific Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Injectable
  • Asia Pacific Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

Middle East and Africa Inflammatory Bowel Disease Treatment Market Assessment

  • Overview
  • Middle East and Africa Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Crohn's Disease
    • Ulcerative Colitis
  • Middle East and Africa Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Corticosteroids
    • Aminosalicylates
    • TNF Inhibitors
    • IL Inhibitors
    • JAK Inhibitors
    • Anti-Integrin
    • Others
  • Middle East and Africa Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Injectable
  • Middle East and Africa Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

South America Inflammatory Bowel Disease Treatment Market Assessment

  • Overview
  • South America Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Crohn's Disease
    • Ulcerative Colitis
  • South America Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Corticosteroids
    • Aminosalicylates
    • TNF Inhibitors
    • IL Inhibitors
    • JAK Inhibitors
    • Anti-Integrin
    • Others
  • South America Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Injectable
  • South America Inflammatory Bowel Disease Treatment Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

Company Profiles

  • AbbVie Inc.
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Takeda Pharmaceutical Company Limited.
  • Pfizer Inc.
  • Biogen
  • Novartis AG
  • Eli Lilly and Company
  • UCB S.A.
  • CELLTRION INC.
  • Merck & Co., Inc.
  • Johnson & Johnson Services, Inc.

Conclusion & Recommendations

  • Insight Code: 5149
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: April 2024
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a dedicated market research professional with over 2 years of experience in the healthcare industry. Specializing in healthcare market research, she brings valuable expertise in analyzing market trends, evaluating industry dynamics, and providing actionable insights to help businesses stay ahead in a competitive market.

Throughout her career, Deepa has focused on delivering in-depth research on various healthcare segments, including pharmaceuticals, biotechnology, and healthcare services. She excels in identifying emerging opportunities, assessing market risks, and understanding regulatory changes that impact the healthcare sector.

Her ability to synthesize complex data and translate it into clear, concise recommendations makes her a key contributor to successful strategic decision-making. Her work helps organizations better understand consumer behavior, market demands, and the regulatory landscape, facilitating informed business strategies.

With a passion for healthcare research and a commitment to excellence, Deepa continues to provide businesses with the market intelligence they need to thrive in an increasingly complex healthcare environment. Her insights are critical for companies seeking to navigate the evolving healthcare landscape and optimize their market positioning.

FAQ's

The expiry of patents for some TNF inhibitor drugs is leading to the introduction of biosimilars. These offer similar efficacy at lower costs, potentially increasing market access for patients and putting pressure on traditional drug prices.

The market is witnessing the rise of new treatment classes like JAK inhibitors, offering alternative options for patients. Additionally, there is growing interest in personalized medicine approaches, tailoring therapy based on individual patient needs and response to specific medications.

High costs of medications, limited access to new therapies in certain regions, and the need for continued development of even more effective and personalized treatment options remain key challenges in the IBD treatment market.

Food and Drug Administration, National Institute of Health, CROHNS & COLITIS FOUNDATION, The Department of Health, State Government of Victoria, Australia.

Warning: include(report-detail-graphs.php): failed to open stream: No such file or directory in /home/thealthcre/public_html/report-toc.php on line 515

Warning: include(): Failed opening 'report-detail-graphs.php' for inclusion (include_path='.:/opt/cpanel/ea-php74/root/usr/share/pear') in /home/thealthcre/public_html/report-toc.php on line 515